News

Bacteria in Patients’ Guts Show Changes That May Weigh on Disease

People with Parkinson’s disease have substantial changes in the bacteria living in their gut relative to people without this neurodegenerative disorder, an analysis underscores. “This dysbiosis [microbial imbalance] might result in a pro-inflammatory status which could be linked to the recurrent gastrointestinal symptoms affecting PD [Parkinson’s disease] patients,” its…

Centogene Enrolls 10K in ROPAD Genetics Study

Centogene has completed enrollment of 10,000 participants in its two-year global study assessing the contribution of genetic factors in the development of Parkinson’s disease. “We are pleased to have reached such a pivotal point in our Parkinson’s disease study,” Peter Bauer, MD, chief genomic officer at Centogene, said…

NeuroSphere Virtual Clinic Connects Patients to Doctors

Abbott has launched its NeuroSphere Virtual Clinic, a U.S. Food and Drug Administration (FDA)-approved digital technology that allows remote patient-doctor communication, increasing medical care access for patients with Parkinson’s disease and other movement disorders. “NeuroSphere Virtual Clinic solves considerable issues patients with movement disorders, such as Parkinson’s disease…

Compound Used to Stop Smoking Can Protect Neurons in Female Mice

A plant-derived medicine used to help people stop smoking, known as cytisine, might be neuroprotective and a potential Parkinson’s disease treatment, an animal model study reports. In female mice, the compound appeared to work with estrogen to limit the loss of the dopamine-producing neurons, nerve cells whose death characterizes…

Experts Recommend COVID-19 Vaccines for Patients, Caregivers

An international team of experts has recommended that people with Parkinson’s disease and their caregivers receive vaccines for COVID-19. The recommendations were published in the Journal of Parkinson’s Disease, in a paper titled, “COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the…